Digestive and Liver Disease Supplements This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Editorial Board
Publication date: December 2010Source: Digestive and Liver Disease Supplements, Volume 4, Issue 1Author(s): (Source: Digestive and Liver Disease Supplements)
Source: Digestive and Liver Disease Supplements - July 10, 2018 Category: Gastroenterology Source Type: research

The Italian clinical experience with adalimumab in Crohn's disease: Eleven clinical cases
Publication date: December 2010Source: Digestive and Liver Disease Supplements, Volume 4, Issue 1Author(s): Maria Laura Annunziata, Fabrizio Bossa, Rosamaria Bozzi, Flavio Caprioli, Andrea Cassinotti, Giuseppe Costantino, Gionata Fiorino, Sara Onali, Mariabeatrice Principi, Sara Renna, Rosy Tambasco (Source: Digestive and Liver Disease Supplements)
Source: Digestive and Liver Disease Supplements - July 10, 2018 Category: Gastroenterology Source Type: research

Spondyloarthropathy associated with Crohn's disease treated with adalimumab
Publication date: December 2010Source: Digestive and Liver Disease Supplements, Volume 4, Issue 1Author(s): Maria Laura Annunziata, Michele Cicala (Source: Digestive and Liver Disease Supplements)
Source: Digestive and Liver Disease Supplements - July 10, 2018 Category: Gastroenterology Source Type: research

Long-term remission with adalimumab in steroid-dependent Crohn's disease patients with multiple drug intolerances
Publication date: December 2010Source: Digestive and Liver Disease Supplements, Volume 4, Issue 1Author(s): Fabrizio Bossa, Giuseppe Biscaglia, Antonio Merla, Fulvia Terracciano (Source: Digestive and Liver Disease Supplements)
Source: Digestive and Liver Disease Supplements - July 10, 2018 Category: Gastroenterology Source Type: research

Adalimumab and endoscopic dilatation in the treatment of inflammatory strictures due to Crohn's disease: A case report of a treatment-naïve patient
Publication date: December 2010Source: Digestive and Liver Disease Supplements, Volume 4, Issue 1Author(s): Rosamaria Bozzi, Pietro Schettino, Angelo Pezzullo, Domenico Cattaneo (Source: Digestive and Liver Disease Supplements)
Source: Digestive and Liver Disease Supplements - July 10, 2018 Category: Gastroenterology Source Type: research

Adalimumab is safe and effective in re-inducing clinical remission after post-surgical relapse of Crohn's disease: A case report
We present the case of a 36-year-old patient with ileo-colonic stricturing Crohn's disease that recurred after surgery, did not respond to maximal medical therapy and was only partially responsive to treatment with adalimumab administered subcutaneously. The patient underwent surgery following an episode of intestinal obstruction, revealing chronic, adhesive peritonitis, with the intestinal loops fixed strongly together, and a fibrotic stricture of the pre-anastomotic ileum. The numerous adhesions were carefully separated and the stenotic tract of ileum was resected. Following the resection the patient had an early clinica...
Source: Digestive and Liver Disease Supplements - July 10, 2018 Category: Gastroenterology Source Type: research

Is mucosal healing a predictor of decreased risk of Crohn's disease relapse after withdrawal of 1-year, successful adalimumab?
Publication date: December 2010Source: Digestive and Liver Disease Supplements, Volume 4, Issue 1Author(s): Andrea Cassinotti, Maria Fichera, Sandro Ardizzone, Gabriele Bianchi Porro (Source: Digestive and Liver Disease Supplements)
Source: Digestive and Liver Disease Supplements - July 10, 2018 Category: Gastroenterology Source Type: research

Prevention of post-surgical recurrence with adalimumab in a patient with complicated Crohn's disease
Publication date: December 2010Source: Digestive and Liver Disease Supplements, Volume 4, Issue 1Author(s): Giuseppe Costantino, Giuseppe Navarra, Luigi Familiari, Walter Fries (Source: Digestive and Liver Disease Supplements)
Source: Digestive and Liver Disease Supplements - July 10, 2018 Category: Gastroenterology Source Type: research

Adalimumab is effective in achieving clinical and endoscopic long-term deep remission: A case report
We report the case of a 61-year-old woman with aggressive and complicated steroid-dependant Crohn's disease in whom clinical and endoscopic long-term deep remission was achieved for up to 3 years, without any need for steroids, hospitalization or surgery. (Source: Digestive and Liver Disease Supplements)
Source: Digestive and Liver Disease Supplements - July 10, 2018 Category: Gastroenterology Source Type: research

Steroid-free remission and closure of recto-vaginal fistula using adalimumab in a Crohn's disease patient naïve to anti-tumour necrosis factor alpha antibodies
Publication date: December 2010Source: Digestive and Liver Disease Supplements, Volume 4, Issue 1Author(s): Sara Onali, Francesca Zorzi, Emma Calabrese, Livia Biancone (Source: Digestive and Liver Disease Supplements)
Source: Digestive and Liver Disease Supplements - July 10, 2018 Category: Gastroenterology Source Type: research

Adalimumab and perianal Crohn's disease: Case report
Publication date: December 2010Source: Digestive and Liver Disease Supplements, Volume 4, Issue 1Author(s): Mariabeatrice Principi, Nicola De Tullio, Alfredo di Leo (Source: Digestive and Liver Disease Supplements)
Source: Digestive and Liver Disease Supplements - July 10, 2018 Category: Gastroenterology Source Type: research

Combined treatment with adalimumab and surgery in a patient with steroid-dependent Crohn's disease complicated by perianal disease
Publication date: December 2010Source: Digestive and Liver Disease Supplements, Volume 4, Issue 1Author(s): Sara Renna, Ambrogio Orlando, Gaspare Solina, Mario Cottone (Source: Digestive and Liver Disease Supplements)
Source: Digestive and Liver Disease Supplements - July 10, 2018 Category: Gastroenterology Source Type: research

Adalimumab in a patient with steroid-dependent Crohn's disease
We present the case of 51-year-old man with stricturing Crohn's disease of the jejunum and ileum who underwent jejunal resection and creation of a latero-lateral anastomosis. The patient had a history of steroid-dependent disease and was inappropriately treated with azathioprine, complicated by vertebral collapse. Adalimumab administered subcutaneously was used because of the persistence of active disease. (Source: Digestive and Liver Disease Supplements)
Source: Digestive and Liver Disease Supplements - July 10, 2018 Category: Gastroenterology Source Type: research

Editorial Board
Publication date: December 2011Source: Digestive and Liver Disease Supplements, Volume 5, Issue 1Author(s): (Source: Digestive and Liver Disease Supplements)
Source: Digestive and Liver Disease Supplements - July 10, 2018 Category: Gastroenterology Source Type: research

2nd Liver Transplantation, HBV and HCV Interdisciplinary Conference
Publication date: December 2011Source: Digestive and Liver Disease Supplements, Volume 5, Issue 1Author(s): Rafael Esteban, Franco Filipponi (Source: Digestive and Liver Disease Supplements)
Source: Digestive and Liver Disease Supplements - July 10, 2018 Category: Gastroenterology Source Type: research